H. Kirchner
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Viral-associated cancers and disorders
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 11
- CAR-T cell therapy research 3
- Immunology 11
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 5
- Co-authors
- Jens Atzpodien (10 shared papers)Heiko Rühl (3 shared papers)H. Poliwoda (10 shared papers)Bernd Metzner (2 shared papers)E Lopez Hänninen (3 shared papers)Iris Dallmann (5 shared papers)Arnold Ganser (2 shared papers)Anette Duensing (2 shared papers)
- Journals
- Transfusion (1 paper)JNCI Journal of the National Cancer Institute (1 paper)Experimental Biology and Medicine (1 paper)Annals of Oncology (1 paper)Journal of Molecular Medicine (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
H. Kirchner
29 papers receiving 657 citations
Peers
Comparison fields: 5 of 76
- Oncology 393
- Immunology 274
- Pathology and Forensic Medicine 157
- Genetics 53
- Pulmonary and Respiratory Medicine 148
Countries citing papers authored by H. Kirchner
This map shows the geographic impact of H. Kirchner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Kirchner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Kirchner more than expected).
Fields of papers citing papers by H. Kirchner
This network shows the impact of papers produced by H. Kirchner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Kirchner. The network helps show where H. Kirchner may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Kirchner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 125 | |
| 2 | 2004 | 112 | |
| 3 | 1995 | 99 | |
| 4 | 1990 | 70 | |
| 5 | 1971 | 48 | |
| 6 | Biological monitoring of low-dose interleukin 2 in humans: soluble interleukin 2 receptors, cytokines, and cell surface phenotypes. | 1991 | 41 |
| 7 | alpha-Interferon and interleukin-2 in renal cell carcinoma: studies in nonhospitalized patients. | 1991 | 29 |
| 8 | European studies of interleukin-2 in metastatic renal cell carcinoma. | 1993 | 23 |
| 9 | Subcutaneous interleukin-2 and interferon-alpha 2b in patients with metastatic renal cell cancer: the German outpatient experience. | 1990 | 23 |
| 10 | Deficient interferon-alpha response of newborns in comparison to adults. | 1993 | 21 |
| 11 | 1971 | 14 | |
| 12 | 1995 | 13 | |
| 13 | 1999 | 13 | |
| 14 | Kinetics of the Zn 2+ - stimulation of human peripheral lmphocytes in vitro. | 1971 | 13 |
| 15 | Long-term effects of 2'-deoxycoformycin treatment on cytokine production in patients with hairy cell leukemia. | 1990 | 12 |
| 16 | 1984 | 12 | |
| 17 | 1989 | 9 | |
| 18 | 2007 | 8 | |
| 19 | 1988 | 7 | |
| 20 | In vivo and ex vivo antitumor activity in patients receiving low-dose subcutaneous recombinant interleukin-2. | 1992 | 7 |
About H. Kirchner
H. Kirchner is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Hematology and Pathology and Forensic Medicine, having authored 29 papers that have together received 721 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (5 papers), Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), Renal cell carcinoma treatment (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Oncology (393 citations), Immunology (274 citations), Pathology and Forensic Medicine (157 citations), Genetics (53 citations) and Pulmonary and Respiratory Medicine (148 citations). H. Kirchner has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Jens Atzpodien, Heiko Rühl, H. Poliwoda, Bernd Metzner, E Lopez Hänninen, Iris Dallmann, Arnold Ganser, Anette Duensing, Jan Buer and Uta Kunter. Their work appears in journals such as Transfusion, JNCI Journal of the National Cancer Institute, Experimental Biology and Medicine, Annals of Oncology and Journal of Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.